Junbo Xia
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
-
- Fungal Biology and Applications
- Pharmacological Effects of Natural Compounds
Papers in
-
- COVID-19 Clinical Research Studies 2
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Jing Zhu (4 shared papers)Changcheng Shi (5 shared papers)Nengming Lin (5 shared papers)Yaping Xie (4 shared papers)Limin Wang (5 shared papers)Qingyu Li (3 shared papers)Renjie Xu (2 shared papers)Jian Ye (3 shared papers)
- Journals
- Chemico-Biological Interactions (2 papers)British Journal of Clinical Pharmacology (1 paper)Frontiers in Pharmacology (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)Allergy and Asthma Proceedings (1 paper)
- Partner nations
- ChinaUnited Kingdom
In The Last Decade
Junbo Xia
22 papers receiving 429 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 130
- Pharmacology 57
- Pharmacology 27
- Biological Psychiatry 6
- Immunology and Allergy 14
Countries citing papers authored by Junbo Xia
This map shows the geographic impact of Junbo Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo Xia more than expected).
Fields of papers citing papers by Junbo Xia
This network shows the impact of papers produced by Junbo Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo Xia. The network helps show where Junbo Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbo Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 112 | |
| 2 | 2018 | 40 | |
| 3 | 2019 | 38 | |
| 4 | 2021 | 33 | |
| 5 | 2008 | 29 | |
| 6 | 2021 | 25 | |
| 7 | 2021 | 22 | |
| 8 | 2017 | 21 | |
| 9 | 2019 | 19 | |
| 10 | 2021 | 17 | |
| 11 | The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice | 2022 | 12 |
| 12 | 2014 | 12 | |
| 13 | 1,25-dihydroxyvitamin D₃ pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model. | 2010 | 11 |
| 14 | Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice. | 2011 | 10 |
| 15 | 2019 | 10 | |
| 16 | 2020 | 7 | |
| 17 | 2023 | 6 | |
| 18 | [The mechanism of airway inflammation in eosinophilic bronchitis and cough variant asthma]. | 2011 | 5 |
| 19 | [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation]. | 2009 | 5 |
| 20 | 2023 | 2 |
About Junbo Xia
Junbo Xia is a scholar working on Infectious Diseases, Molecular Biology, Physiology, Epidemiology and Immunology, having authored 23 papers that have together received 438 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (3 papers), Allergic Rhinitis and Sensitization (2 papers), Pediatric health and respiratory diseases (2 papers), Influenza Virus Research Studies (2 papers), Immunotherapy and Immune Responses (2 papers), COVID-19 Clinical Research Studies (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Infectious Diseases (130 citations), Pharmacology (57 citations), Pharmacology (27 citations), Biological Psychiatry (6 citations) and Immunology and Allergy (14 citations). Junbo Xia has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Jing Zhu, Changcheng Shi, Nengming Lin, Yaping Xie, Limin Wang, Qingyu Li, Renjie Xu, Jian Ye, Zhi‐Chun Gu and Shuying Wang. Their work appears in journals such as Chemico-Biological Interactions, British Journal of Clinical Pharmacology, Frontiers in Pharmacology, Frontiers in Bioengineering and Biotechnology and Allergy and Asthma Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.